SCHEMBL14478659

SCHEMBL14478659

c1ccc(-c2ccc(-c3cc4c5ccccc5c5ncc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5c4c4ccccc34)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 4/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ TNIK Q9UKE5 1/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ NFKB1 P19838 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ NFKB2 Q00653 2/20 0.37
▸ RELA Q04206 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ SGK1 O00141 4/20 0.36
▸ CAMKK2 Q96RR4 1/20 0.36
▸ MET P08581 1/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MPI P34949 1/20 0.35
▸ MAPK10 P53779 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14478654 0.91 KDM4E (0.38) AXLCDK8TNIKNPC1NFKB1
SCHEMBL14478673 0.90 ADORA2A (0.40) NPC1RAB9ASMN1; SMN2SGK1MET
SCHEMBL20624217 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623637 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623981 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623928 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623934 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623677 0.84 MEN1 (0.46) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20624548 0.82 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623924 0.80 MEN1 (0.40) NFKB1NFKB2RELASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8986855-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-24 — — US disclosed
US-8986855-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-24 — — US disclosed
US-8951649-B2 — — 2015-02-10 — — US disclosed
US-8951649-B2 — — 2015-02-10 — — US disclosed
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-01-03 — — US disclosed
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, ORC3, NR2E3 AXL 924/4885CDK8 897/4885TNIK 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback